Press Releases

Press Releases

Filters
Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
Viatris Announces Cash Tender Offers for Certain Outstanding Notes
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress
Viatris Reports Second Quarter Financial Results for 2024
Viatris Announces Second Quarter 2024 Dividend
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over-the-Counter Business to Cooper Consumer Health
Displaying 11 - 20 of 137